What's New in Critical Illness and Injury Science? Weighing the evidence for dexmedetomidine dosing in critically ill patients with obesity
- PMID: 37547191
- PMCID: PMC10401556
- DOI: 10.4103/ijciis.ijciis_25_23
What's New in Critical Illness and Injury Science? Weighing the evidence for dexmedetomidine dosing in critically ill patients with obesity
References
-
- Adult Obesity Facts. Centers for Disease Control and Prevention (CDC); 2022. [[Last accessed on 2023 Jun 07]]. Available from: https://www.cdc.gov/obesity/data/adult.html .
-
- Cho SJ, Yoon IS, Kim DD. Obesity-related physiological changes and their pharmacokinetic consequences. J Pharm Investig. 2013;43:161–9.
-
- Pai MP. Drug dosing based on weight and body surface area:Mathematical assumptions and limitations in obese adults. Pharmacotherapy. 2012;32:856–68. - PubMed
-
- Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJ, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46:e825–73. - PubMed
Publication types
LinkOut - more resources
Full Text Sources